The FDA has placed an Investigational Drug For Sickle Cell Disease on Clinical Hold
geralt / Pixabay

The FDA has placed an Investigational Drug For Sickle Cell Disease on Clinical Hold

The Investigational New Drug Application for the experimental drug CTX001 for treating sickle cell disease has been put on clinical hold, announced Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics. This hold…

Continue Reading The FDA has placed an Investigational Drug For Sickle Cell Disease on Clinical Hold
The FDA Has Awarded Breakthrough Therapy Designation to an Experimental Drug for Treating Some Forms of Lung Cancer and Anaplastic Large Cell Lymphoma
Source: Pixabay

The FDA Has Awarded Breakthrough Therapy Designation to an Experimental Drug for Treating Some Forms of Lung Cancer and Anaplastic Large Cell Lymphoma

Pfizer has announced that the medicine Xalkori (crizotinib) has received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for two potential treatment uses. The full article can be…

Continue Reading The FDA Has Awarded Breakthrough Therapy Designation to an Experimental Drug for Treating Some Forms of Lung Cancer and Anaplastic Large Cell Lymphoma
Chin Hairs in Women Could be Indicators of Cushing Syndrome or Congenital Adrenal Hyperplasia
Giuliamar / Pixabay

Chin Hairs in Women Could be Indicators of Cushing Syndrome or Congenital Adrenal Hyperplasia

According to a story from msn.com, a significant portion of woman may notice a small number of hairs growing on their chin at some point in their lives. In most…

Continue Reading Chin Hairs in Women Could be Indicators of Cushing Syndrome or Congenital Adrenal Hyperplasia
Gene Therapy Could Put an End to Blood Transfusions for Beta Thalessemia Patients
JuralMin / Pixabay

Gene Therapy Could Put an End to Blood Transfusions for Beta Thalessemia Patients

According to a story from empr.com, a recent study revealed that gene therapy could allow patients with beta thalessemia to stop having to get regular blood transfusions. The gene therapy…

Continue Reading Gene Therapy Could Put an End to Blood Transfusions for Beta Thalessemia Patients

Updated Results From Cancer Drug Trial Show Greater Improvements Than Previously Reported

According to a story from Reuters, the cancer drug developer Loxo Oncology recently released the latest results from the trial testing its investigational therapy LOXO-292. Preliminary results released about a…

Continue Reading Updated Results From Cancer Drug Trial Show Greater Improvements Than Previously Reported